GE Healthcare and BAC start collaboration in biopharmaceutical purification
Advertisement
GE Healthcare and BAC BV announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area. Under the terms of the agreement, the two companies plant to develop new affinity chromatography media for human antibodies and adeno-associated virus (AAV) viral vector purification. The first products are expected to be commercially available during 2007 through GE Healthcare's Custom Designed Media business. The collaboration is expected to generate several new innovative affinity chromatography media solutions for biopharmaceutical manufacture and drug discovery research.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Genmab announces early results of ongoing HuMax-CD4 trials
'Poisoned arrowhead' used by warring bacteria could lead to new antibiotics
FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011
New therapeutic approach identified for kidney disease associated with lupus
YM BioSciences reports Nimotuzumab approved for marketing in Mexico - YM enrolls first patients in multinational randomized, double-blind brain metastases trial
Johns Hopkins biologist leads research shedding light on stem cells
Scientists unearth what may be secret weapon against antibiotic resistance
Veterinary vaccines found to combine into new viruses, prompting regulatory response
Fine-tuned test predicts risk of ovarian cancer with great precision
Medarex and GenPat77 Announce Therapeutic Antibody Co-Development Agreement